Search Results 201-210 of 10599 for Terminal

1. Acupuncture For The Treatment of Autonomic Dysfunction - Mayo Clinic

   Terminal illness; Active Sepsis/Bacteremia. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to ...

2. Metastatic Non-Small Cell Lung Cancer Insomnia - Mayo Clinic

   Participation eligibility · Have advanced terminal cancer, severe depression, or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, ...

3. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy - Mayo Clinic

   * Has screening N-terminal prohormone B-type natriuretic peptide (NT-proBNP) \>300 ng/L and \<8500 ng/L; In patients with permanent or persistent atrial ...

4. Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

   Terminal illness other than HF, such as malignancy, or with a life expectancy of less than 1 year as determined by the enrolling clinician-investigator.

5. Spine Clinic - Anticipatory Thinking (AT) in Patient Care Scenarios

   If a patient has between 1 and 2 years of interaction, then a “terminal event” will be appended to the data. If a patient has more than 2 years of ...

6. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

   ... terminal half-life of luspatercept based on multiple-dose pharmacokinetics [PK] data) after discontinuation of study therapy. Male subjects must: Practice ...

7. Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes In Heart Failure - Mayo Clinic

   a plasma B-type Natriuretic Peptide (BNP) level ≥ 300 pg/ml or N-terminal prohormone of brain natriuretic peptide (NT-proBNP) ≥1800pg/ml measured during a ...

8. Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease - Mayo Clinic

   * Known allergies to any of the components of the compression. * Terminal illness or current cancer therapy with chemotherapy * Inability to undergo ongoing ...

9. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   ... terminals, to assess the pharmacokinetic (PK) profile of BIIB054 and to evaluate the immunogenicity of BIIB054. Participation eligibility. Participant ...

10. Chronic traumatic encephalopathy - Symptoms and causes - Mayo Clinic

    This brain disease is likely caused by repeated concussions, but this condition isn't well understood.